Search Results

Authors Ze Wu , Qiongqiong Jia , Boqun Liu , Lanlan Fang , Peter C K Leung , Jung-Chien Cheng Tags Invasion

and Immunology Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia Published date June Authors Guangrong Qin, Jin Dai, Sylvia Chien, Timothy J Martins, Brenda Loera, Quy H Nguyen, Melanie

Juan José Fung About Dr. Juan José Fung Dr. Juan José Fung is a Principal Scientist at GPCR Therapeutics, Inc , a drug discovery company focused Fung received his Ph.D. from the Stanford University School of Medicine under the mentorship of Dr. Fung continued his Postdoctoral training in Dr. Juan José Fung on the web LinkedIn GPCR Therapeutics Dr.

apoptosis in colorectal cancer through disrupting TRAF6-TAB2-TAK1-JNK/p38 MAPK signaling Published date June Authors Hao Shen, Jie Yuan, Dafeng Tong, Bingchen Chen, Enda Yu, Guanglei Chen, Cheng Peng, Wenjun Chang

demonstrate its ability to promote cancer cell motility. " Authors Yu Jin Lee , Kyeong Jin Shin , Hyun-Jun Jang , Jin-Sun Ryu , Chae Young Lee , Jong Hyuk Yoon , Jeong Kon Seo , Sabin Park , Semin Lee , A Reum

Immunology Minireview: functional roles of tissue kallikrein, kinins, and kallikrein-related peptidases in lung Published date July 3, 2023 Abstract "Despite campaigns and improvements in detection and treatment, lung One approach to treating patients suffering from lung cancer is to target surface receptors overexpressed Since lung cancer is often diagnosed in advanced stages, our efforts should focus on early diagnosis, Furthermore, their modulation could be considered as a promising approach in lung cancer therapeutics

intellectual property, and at the Mintaka Foundation for Medical Research with a role as co-founder and Chief

, Maria worked several years at Novo Nordisk before joining InterAx Biotech in Switzerland as their Chief

Dr Gendron is co-director of the FRQS-funded Quebec Pain Research Network and the Editor-in-Chief in

He is currently the Senior Investigator and Chief of the Molecular Recognition Section, Laboratory of

., is our co-founder and has served as our President and Chief Executive Officer since December 2008.

He served as Branch Chief at NIDCR, NIH, since 1998 until his recruitment to UCSD in 2015.

< GPCR News < GPCRs in Oncology and Immunology A2aR on lung adenocarcinoma cells: A novel target for Here, we identify that A2aR is specifically expressed on tumor cells from lung adenocarcinoma (LUAD) , Xin Zhang , Jiawei Zhou , Jianqiang Guo , Yafeng Liu , Chao Liang , Wenyang Wang , Yingru Xing , Jing Tags A2aR , Lung adenocarcinoma , Migration , Polarization , Targeted therapy , Tumor-associated macrophages

Since 2019, Nick has combined his university role with the leadership of Excellerate Bioscience as Chief

Aaron is currently the Chief Scientific Officer and VP of Protein Engineering.

Deputy Director of the Australian Research Council Centre for Personalised Therapeutics Technologies, Chief

Network (IRN) i-GPCRnet of the CNRS, is chair of IUPHAR « Melatonin receptor » sub-committee, Editor-in-Chief

< GPCR News < GPCRs in Oncology and Immunology RGS20 promotes non-small cell lung carcinoma proliferation Background: Novel therapeutic targets are urgently needed for treating drug-resistant non-small cell lung Methods: Immunohistochemistry and lung cancer tissue microarray were used to verify the expression of Immunofluorescence was used to detect the translocation changes of YAP to nucleus. the role of RGS20 as a promising novel molecular marker and a target for future targeted therapies in lung

occupancy of Histone H3 Lysine 4 methylation in the cells treated with TGFβ and Interferonγ Published date June signalling, it would be of utmost importance to find out the regions undergoing histone modification changes

John Teye Azietaku Get in touch Chief Matchmaker Mark Schmeizl Get in touch

News < GPCRs in Oncology and Immunology Regulator of G protein signaling protein 6 alleviates acute lung HE staining, ELISA, and immunohistochemistry were used to evaluate pathological changes and the degree vitro, qRT‒PCR, immunofluorescence staining, and western blotting were used to determine the dynamic changes Compared with the control group, we found higher mortality, more pronounced body weight changes, more Authors Juan Song , Miao Li , Cuicui Chen , Jian Zhou , Linlin Wang , Yu Yan , Jun She , Lin Tong , Yuanlin

the proliferation, migration and autophagy of hepatocellular carcinoma cells in vitro Published date June Authors Weiming Zhao , Lingling Xi , Guoying Yu , Gaiping Wang , Cuifang Chang Source Contribute to the

cancer incidence trends in Golestan, Iran: An age-period-cohort analysis 2004 to 2018 Published date June The estimated annual percentage change (EAPC) with 95% confidence interval (95% CI) were calculated. The marked declines in EC incidence rates in Golestan relate to generational changes in its underlying

Immunology Autocrine proteinase-activated receptor signaling in PC3 prostate cancer cells Published date June

G protein-coupled receptor 37 promotes resistance to cisplatin-induced apoptosis in non-small cell lung cancer Published date September 21, 2023 Abstract "Objectives: Lung cancer is a major public health protein-coupled receptor 37 (GPR37) exhibits unknown functions in tumors, particularly in non-small-cell lung Authors Han Liu , Yingjie Zhu , Huikun Niu , Jing Jie , Shucheng Hua , Xiaoxue Bai , Shuai Wang , Lei

Individual cells trend to adapt environmental changes in a "whole" flora through communications, allowing Authors Jing Gao, Huiqing Liu, Yuxin Jin, Yunbo Luo, Kunlun Huang, Zhihong Liang Tags Cell communication

Jinqiancao granules for the treatment of prostatitis and benign prostatic hyperplasia Published date June this medicine consists of four herbs: Desmodium styracifolium (Osbeck) Merr., Pyrrosia calvata (Baker) Ching

Before founding G.CLIPS biotech in June 2020.